Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Scleroderma and related conditions

H Mitchell1, M B Bolster, E C LeRoy

  • 1Department of Medicine, Medical University of South Carolina, Charleston, USA.

The Medical Clinics of North America
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Has the HCV cascade of care changed among people who inject drugs in England since the introduction of direct-acting antivirals?

The International journal on drug policy·2024
Same author

Factors associated with emergency admission for people dying from cancer in Northern Ireland: an observational data linkage study.

BMC health services research·2023
Same author

The verification of wildland-urban interface fire evacuation models.

Natural hazards (Dordrecht, Netherlands)·2023
Same author

Nosocomial acquisition of influenza is associated with significant morbidity and mortality: Results of a prospective observational study.

Journal of infection and public health·2022
Same author

An updated report on the incidence and epidemiological trends of keratinocyte cancers in the United Kingdom 2013-2018.

Skin health and disease·2022
Same author

A summary of the updated report on the incidence and epidemiological trends of keratinocyte cancers in the UK 2013-2018.

The British journal of dermatology·2021
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Systemic sclerosis is a complex fibrotic disease affecting multiple organs. Early diagnosis is crucial for managing complications and improving patient quality of life.

Area of Science:

  • Rheumatology
  • Internal Medicine
  • Pathophysiology

Background:

  • Systemic sclerosis is a generalized connective tissue disease.
  • It is characterized by fibrosis and microvascular injury.
  • Limited understanding of pathogenesis hinders effective treatment.

Purpose of the Study:

  • To highlight the importance of early recognition of systemic sclerosis.
  • To emphasize monitoring for specific disease complications.
  • To promote timely initiation of manifestation-specific therapies.

Main Methods:

  • This abstract does not detail specific methods.
  • Focus is on clinical recognition and management principles.
  • Literature review and clinical expertise synthesis.

Related Experiment Videos

Main Results:

  • Early recognition facilitates monitoring for fibrosing alveolitis and scleroderma renal crisis.
  • Prompt intervention can improve quality of life.
  • Current treatments focus on symptomatic improvement.

Conclusions:

  • Early detection of systemic sclerosis is critical for proactive management.
  • Targeted therapies based on manifestations can enhance patient outcomes.
  • Further research into pathogenesis is needed for improved treatments.